Tahari, Albaser M.
HRN: 22-71-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2023
AMPICILLIN 250MG (VIAL)
07/11/2023
07/17/2023
IVT
150
Q6
AGE With Moderate Dehydration; URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes